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Background: Postoperative delirium is prevalent in older patients and associated with worse outcomes. Recent
data in animal studies demonstrate increases in inflammatory markers in plasma and cerebrospinal fluid (CSF) even
after aseptic surgery, suggesting that inflammation of the central nervous system may be part of the pathogenesis
of postoperative cognitive changes. We investigated the hypothesis that neuroinflammation was an important
cause for postoperative delirium and cognitive dysfunction after major non-cardiac surgery.
Methods: After Institutional Review Board approval and informed consent, we recruited patients undergoing major
knee surgery who received spinal anesthesia and femoral nerve block with intravenous sedation. All patients had an
indwelling spinal catheter placed at the time of spinal anesthesia that was left in place for up to 24 h. Plasma and
CSF samples were collected preoperatively and at 3, 6, and 18 h postoperatively. Cytokine levels were measured
using ELISA and Luminex. Postoperative delirium was determined using the confusion assessment method, and
cognitive dysfunction was measured using validated cognitive tests (word list, verbal fluency test, digit symbol test).
Results: Ten patients with complete datasets were included. One patient developed postoperative delirium, and
six patients developed postoperative cognitive dysfunction. Postoperatively, at different time points, statistically
significant changes compared to baseline were present in IL-5, IL-6, I-8, IL-10, monocyte chemotactic protein
(MCP)-1, macrophage inflammatory protein (MIP)-1α, IL-6/IL-10, and receptor for advanced glycation end
products in plasma and in IFN-γ, IL-6, IL-8, IL-10, MCP-1, MIP-1α, MIP-1β, IL-8/IL-10, and TNF-α in CSF.
Conclusions: Substantial pro- and anti-inflammatory activity in the central neural system after surgery was found. If
confirmed by larger studies, persistent changes in cytokine levels may serve as biomarkers for novel clinical trials.
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Cognitive impairment, including the conditions of post-
operative delirium [1, 2] and postoperative cognitive dys-
function (POCD) [2, 3], is frequently observed after major
surgery, particularly in older patients [3–7]. Postoperative
delirium is associated with increases in length of hospital
stay, admissions to long-term care institutions, long-term
functional decline, and long-term mortality [8]. POCD,
which is measured by cognitive testing, has been similarly
shown to be associated with premature inability to work,
dependency on social transfer payments, inability to cope
independently, and long-term mortality [7, 9]. Although
risk factors such as advanced age and neurodegenerative
processes have been identified [5], the pathophysiology for
either condition is still unclear.
Orthopedic procedures may result in extensive trauma,
tissue injury, and blood loss, which can engage the in-
nate immune system [10]. Preclinical studies suggest
that inflammation is a possible pathogenic mechanism
for POCD [11–15]. In particular, increased expression of
cytokines in a rodent’s hippocampus following surgery
was associated with cognitive decline [12, 16, 17]. Puta-
tive mediators of this postoperative neuroinflammatory
response include interleukin (IL)-1β [12], IL-6, tumor
necrosis factor-α (TNF-α), and high-mobility group box
1 protein (HMGB1) [16, 18].
Some studies suggest that surgical patients also exhibit
elevations of proinflammatory cytokines in the central
nervous system and systemic circulation [19–23]. How-
ever, three of these studies were performed in patients
who had sustained traumatic injury prior to surgery;
thus, the preceding trauma may have contributed to
inflammation [19–21]. One study was performed in
patients who underwent correction of idiopathic nasal
cerebrospinal fluid (CSF) leak [24]. In this setting, the
perforation of the blood-brain barrier due to the under-
lying pathology may have led to biomarker increases in
the CSF that cannot be clearly differentiated from the
changes induced by surgery. Another research team
evaluated biomarkers in patients who received concur-
rent continuous infusion of bupivacaine into the spinal
space through the same indwelling spinal catheter that
was used for sampling [22, 23, 25, 26]. Given bupiva-
caine’s anti-inflammatory properties and potential asso-
ciation with chemical meningitis [27, 28], the reported
results may have been confounded by this concurrent
administration [29–31].
To address the potential relationship between surgery,
systemic and central inflammatory biomarkers, and post-
operative cognitive changes, we designed a prospective
cohort pilot study. The study was performed in patients
undergoing elective major knee surgery, a clinical
equivalent of our previous preclinical model of aseptic
surgery [11–13].We hypothesized that aseptic surgery resulted in sys-
temic inflammation and inflammation of the central ner-
vous system. Results from this study will enable us to
design future larger studies to test the hypothesis that
persistent and excessive neuroinflammation caused by
aseptic surgery triggers postoperative cognitive changes.
Methods
Study population
We included patients aged ≥55 years that were scheduled
for elective major knee surgery who spoke English as the
primary language. We included a broader age range to
maximize patient recruitment. Exclusion criteria were
pre-existing impaired cognition and contraindications for
spinal anesthesia including anticoagulants, recent history
of alcohol or drug abuse, or opioid tolerance.
The preoperative interview was conducted by a trained
research assistant. Information from the preoperative
physical exam including American Society of Anesthe-
siologists classification, preoperative use of opioids and
benzodiazepines, and preoperative pain level (using the
eleven-point numeric rating scales (NRS) from “no
pain” (0/10) to “worst possible pain” (10/10) [32]) were
recorded.
Cognitive testing
All cognitive testing was performed by research assis-
tants who had received training in the administration of
these tests and were supervised by an experienced inves-
tigator (JL) [33]. In addition, all cognitive results were
validated by a third investigator with advanced training
in cognitive testing (LS). Delirium was determined using
the confusion assessment method (CAM) [34] pre- and
postoperatively daily until hospital discharge. CAM was
developed as a screening instrument based on operatio-
nalization of the Diagnostic and Statistical Manual of
Mental Disorders Version III, Revised (DSM-III-R) cri-
teria for use by clinicians not formally trained in psych-
iatry in high-risk settings. Identifying delirium using
CAM requires the presence of acute onset and fluctuat-
ing course, inattention, and either disorganized thinking
and/or altered level of consciousness. If administered by
trained research personnel to patients with sufficient
level of arousal to be assessed, CAM has a sensitivity of
94–100 %, a specificity of 90–95 %, a high inter-observer
reliability [34] and a convergent agreement with four
other cognitive status tests. The research assistants were
trained in the use of CAM until the inter-rater reliability
reaches 0.96, based on a detailed manual developed for
the administration of CAM [34]. At approximately 24 h
after surgery, the patient was rated on the Richmond
Agitation and Sedation Scale (RASS) [35]. If a patient
was too sedated to be interviewed (RASS score of −4
or −5), delirium status could not be assessed.
Hirsch et al. Journal of Neuroinflammation  (2016) 13:211 Page 3 of 12POCD was determined using a battery of validated
cognitive tests preoperatively and on postoperative days
1 to 3. The word list test measures the patients’ verbal
memory [36]. The verbal fluency measures executive
function and linguistic skills. The digit symbol test
measures incidental memory, scanning, and motor
speed [37]. Perioperative changes in scores for the
cognitive tests were computed separately for each test
by subtracting the postoperative test scores from the
preoperative test score. Prior research validated that
decline of four or more points on the word list or a
decline of seven in the symbol or verbal fluency rep-
resents significant decline in cognitive performance
[36–38]. Patients without delirium who decline on at
least two cognitive tests for any postoperative day
were designated as having POCD [38].
Study protocol
A femoral nerve catheter was placed immediately pre-
operatively. In the operating room and after intravenous
administration of 1–2 mg of midazolam to reduce anxiety,
a spinal catheter was placed and baseline blood and CSF
samples were collected. Subsequently, a single dose of
hyperbaric bupivacaine 0.75 % was administered through
the catheter. Intraoperatively, patients received intraven-
ous propofol infusion titrated by the anesthesiologist for
comfort while maintaining arousability and airway protec-
tion (Ramsay scores 4–5). Subsequent sampling of the
blood and CSF was performed 3, 6, and 18 h after the end
of the surgical procedure.
Biochemical analysis
CSF and plasma samples were collected using appropriate
tubes (Becton Dickinson Vacutainer, BD Diagnostics, NJ).
Samples were immediately centrifuged at 1000 × g force
for 20 min. and aliquots were stored at −80 °C.
Cytokine testing
Matching plasma and CSF were assayed using a high-
sensitivity Milliplex kit (Millipore, Billerica, MA) with
antibody-coated beads for detection of interferon (IFN)-γ,
IL-10, IL-12p70, IL-2, IL-4, IL-5, IL-6, IL-8, and TNF-α
(standard curve range 0.13 to 2000 pg/mL). A standard
sensitivity Milliplex Map kit (Millipore) was used for IFN-
γ2, monocyte chemotactic protein (MCP)-1, macrophage
inflammatory protein (MIP)-1α, and MIP-1β (standard
curve range 3.2 to 10,000 pg/mL). A neurodegenerative
Milliplex Map kit (Millipore) was used to measure
amyloid β-40, amyloid β-42, and receptor for advanced
glycation end products (RAGE) (standard curve range
3.4–15,000 pg/mL). Calprotectin (MRP8/14) was mea-
sured by enzyme-linked immunosorbent assay (ELISA)
with a 1:40 dilution (BioLegend, San Diego; standard
curve range 120 to 80,000 ng/mL). Testing wasperformed following the manufacturer’s protocols.
Standard and patient samples were tested in duplicates.
Milliplex results were acquired on a LABScan 200
analyzer (Luminex, Austin, TX) using Bio-Plex manager
software (Bio-Rad, Hercules, CA), and study plates
were compiled using Data Pro (Bio-Rad). ELISA assays
were read by SoftMax Pro version 5. All multiplex ana-
lyses were done in the research laboratories of the
Blood Centers of the Pacific, San Francisco, CA. Plasma
and CSF IL-1β and HMGB1 were measured in duplicates
using ELISA following the manufacturer’s protocols (R&D
Systems, Minneapolis, MN; IBL International, Toronto,
Ontario, Canada, and BioLegend, San Diego, CA, respec-
tively).The detection limits for IL-1β as supplied by the
manufacturer was 3.9–250 pg/mL and for HMGB1,
2.5–80 ng/mL (high-sensitivity assay procedure: 0.2–
10 ng/mL; high sensitivity was used where regular assay
procedure did not give a result).
Statistical analysis
Inflammatory marker data are presented as mean
(±standard deviation (SD)) and ranges in Additional file
1. Data analysis was performed using Microsoft® Excel
and Statistics and Analytics System (SAS) V.9.3 for
Windows. The linear mixed effects model was applied
to statistically compare longitudinal changes (i.e., 3, 6,
and 18 h) after surgery. To correct for multiple com-
parisons within a type of cytokine, we first conducted
an overall test for change and then computed post hoc
tests only when the overall test was significant. For the
other research question about whether change occurred
for any of the 17 assessments of plasma levels of cyto-
kines and 15 assessments of CSF levels of cytokines, a
correction for multiple comparisons would be neces-
sary (data not shown).
Definitions
Dependent variables
Separate linear mixed effects models were fitted for
different plasma-CSF cytokines. The dependent variables
for a single model are differences between the preopera-
tive measure and the postoperatively measured cytokine
level at 3, 6, and 18 h, respectively, of a specific inflam-
matory marker. The linear mixed effects model takes
into account within subject correlations among the
changes in the cytokine from the baseline over time.
Between-subject changes in cytokines over time were
treated as independent.
Independent variables
The primary independent variable group is defined as
the presence or absence of POCD or delirium. This
allowed assessment of whether there were different
trends in the changes of postoperative cytokine from the
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without POCD/delirium. The independent variables or
covariates that were not significant (p value > 0.1) were
excluded from the model, except for the case when no
independent variable is significant; in this case, the
group effect is the only included independent variable.
Included in each model was a time variable to determine
whether there were changes in cytokine levels across
the three repeated measurements (3, 6, and 18 h after
surgery). In addition, we incorporated a group*time
interaction to test whether the two groups differed in
patterns of change over time.Statistical approach
To test the hypothesis (cytokine at x hours significantly
changed from the preoperative measurement) is equiva-
lent to test whether a linear combination of the fixed
effects coefficients is different from 0. For example, if
the fixed effects contain linear time trend, quadratic
time trend, and the group effect, the mean of change
in cytokine at time t from the baseline is β0 þ β1t þ β2
t2 þ group1 for the subjects with POCD/delirium and
β0 þ β1t þ β2t2 þ group0 for the subjects without
POCD/delirium, respectively. Thus, to test the hypoth-
esis that the change for group 1 (i.e., the POCD/delir-
ium group) at time t is not 0 is equivalent to test
β0 þ β1t þ β2t2 þ group1≠0 , which can be achieved
using the “contrast” or “estimate” functions in SAS.
Determination of the covariance structure (e.g., either
random intercept or random intercept and slope model
was applied) was based on the Akaike information cri-
terion (AIC). The model parameters were estimated by
the restricted maximum likelihood method. The stand-
ard errors were computed using the Kackar and HarvilleTable 1 Patient demographics. A trained research assistant assessed
postoperative delirium, including age, gender, race, level of educatio
Patients were as well evaluated for the presence of CNS disorders (h
depression, and seizure) by chart review and through the perioperat
Gender Age History of
CNS disorders
Other comorbidities
Patient-001 F 66 Depression
Patient-003 F 84 Hypertension
Patient-004 M 76 General Fatigue
Patient-005 M 75 Ischemic heart disease
Patient-006 (delirium) M 75 Hypertension, valvular
Patient-007 M 61 Ischemic heart disease
Patient-008 F 64 Psychiatric Depression, hypertens
Patient-009 M 80 Hypertension, renal dis
Patient-010 M 63 Hypertension, diabetes
Patient-011 M 59 Asthmaapproximation [39], and degrees of freedom were com-
puted by the Kenward and Rogers [40] method.
Results
Recruitment is summarized in a summary and flow dia-
gram in Additional file 2. A total of 141 patients were
asked to participate in the study between 12/2010 and
4/2013. Sixty-nine patients declined, 29 patients were
ineligible due to medical conditions, and 17 for other
reasons. Eight patients were removed after starting the
study (causes explained in Additional file 2). Sampling
was performed without complications in ten patients;
this cohort forms the basis of the report. Nine patients
underwent total knee arthroplasty, and one patient had
a knee extensor tendon reconstruction with allograft.
The mean age of the patients was 70.3 (8.7) years, range
59–84 years. The average blood loss was 105 (16) ml,
average tourniquet time was 21 (21) min, and bone ce-
ment was used in 9/10 patients. At 24 h after surgery,
the catheter was removed in all patients. No patient de-
veloped complications related to the study procedure.
CSF and plasma cytokine analysis was performed in all
ten patients. Demographics and comorbidities are sum-
marized in Table 1 (patient characteristics). Data for
the patients that underwent baseline cognitive testing,
but were ultimately not included in the study, are pro-
vided in Additional file 3c.
Postoperative delirium
Preoperatively and on the subsequent two postoperative
days, CAM could be performed on all patients as none
were too sedated (Additional file 3a). For eight of the
patients, the test for delirium was obtained on postop-
erative day 3 as well, since two patients were discharged
after 2 days.health and demographic information associated with
n, daily alcohol consumption, and baseline cognitive status.
istory of stroke or transient ischemic attacks, delirium, dementia,







, hypertension, valvular heart disease, arrhythmia, COPD, melanoma 3
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1 which was resolved and was not detected in the subse-
quent two postoperative days of observation.
Postoperative cognitive dysfunction
Four patients (patient numbers 4, 5, 8, and 10) had evi-
dence of a significant decline in two tests for POCD on
post operative day 1, two on postoperative day 2 (patients
4 and 5), and four on postoperative day 3 (patients 3, 4, 5,
and 9). Of note, four patients did not have cognitive test
results for POCD on postoperative day 3. Patient 5 had a
decline in all three tests on postoperative day 2. The de-
tailed tests and interpretation of results are summarized
in Additional file 3b. In none of the patients that tested
positively for POCD the cognitive impairment was noticed
by caregivers and study personnel not involved in cogni-
tive testing or commented on by the patients during visits.
Inflammatory response after surgery in patients with and
without postoperative cognitive changes
Biochemical analyses were performed in ten patients
with complete sample sets. Due to the sample size, patients
with postoperative cognitive changes (delirium and POCD)
were statistically analyzed in one group.
We observed an increase in proinflammatory cytokines
from the baseline, in particular, in CSF, in the first 18 h
after surgery (Figs. 1 and 2, Tables 2 and 3). Data and
descriptive statistics are provided in Additional file 1
and detailed statistical results on all parameters in
Additional file 4.
Plasma IL-5 and plasma IL-8 showed a strong different
trend of their values from the preoperative measure
between patients with and without postoperative cogni-
tive changes (Table 2 and Fig. 2). While the overall dif-
ference between groups was not statistically significant
(p = 0.0784 and p = 0.0703, respectively), there were sta-
tistically significant differences between preoperative and
postoperative values at different time points. For IL-5,Fig. 1 Time course of inflammatory markers MCP-1, interleukins 6 and 8, an
increased CSF levels in some patients. Of these, NIP 6 is the patient who d
Conversely, NIP 4 and 10 had no increase in these cytokines while developthere was a statistically significant increase in the
POCD/delirium group at 18 h after surgery compared
to baseline (p = 0.0333) (Fig. 2 and Table 2). For IL-8,
we identified a significant increase in the POCD/delir-
ium group compared to baseline at all time points (3 h
p = 0.0161; 6 h p < 0.0001; 18 h p < 0.0001), and in the
group without cognitive postoperative changes at 6 h
(p = 0.0039) and 18 h (p = 0.0014).
Some of the other plasma cytokines had significantly
elevated postoperative values with a (marginally) sig-
nificant time trend in the postoperative changes but
without a clear trend between patients with and with-
out postoperative cognitive changes (Table 2): IL-6 (3 h
p = 0.5151; 6 h p < 0.0001; 18 h p < 0.0001), MCP-1 (3 h
p = 0.0821; 6 h p = 0.0007; 18 h p = 0.0826), IL-6/IL-10
(3 h p = 0.4634; 6 h p = 0.1278; 18 h p = 0.0016), and
MIP-1α (3 h p = 0.0132; 6 h p = 0.0217; 18 h p =
0.2268), as well as of the anti-inflammatory IL-10 (3 h
p = 0.1938; 6 h p = 0.0071; 18 h p < 0.0001).
We observed that there was a (marginally) signifi-
cant time trend for CSF markers but without a clear
difference between the two groups. A (marginally)
significant change was found for proinflammatory
IL-5 (3 h p = 0.0626; 6 h p = 0.4604; 18 h p = 0.0465),
IL-6 (3 h p = 0.2297; 6 h p = 0.0254; 18 h p < 0.0001),
IL-8 (3 h p = 0.7260; 6 h p = 0.0021; 18 h p = 0.0037),
MCP-1 (3 h p = 0.6580; 6 h p < 0.0001; 18 h p =
0.0014), MIP-1α (3 h p = 0.0130; 6 h p = 0.0087; 18 h
p = 0.0012), MIP-1β (3 h p = 0.0036; 6 h p = 0.0027;
18 h p = 0.0196) (Table 3), and IL-8/IL-10 (3 h p =
0.8340; 6 h p = 0.0858; 18 h p = 0.1649). Figure 1 il-
lustrates the CSF course of the four proinflammatory
cytokines MCP-1, IL-6, IL-8, and TNF-α for all
patients.
IL-1β was below the detection threshold for most
samples in both plasma and CSF. For HMGB1, we had
previously reported a similar pattern with substantial
increases in a smaller subset of these patients [18].d tumor necrosis factor α over the perioperative period shows
eveloped postoperative delirium, NIP 3, 5, 8, and 9 developed POCD.
ing POCD
Fig. 2 Left Column: Calculated difference between postoperative measurements and baseline measurements for plasma IL-5 and IL-8, plotted
separately for patients with and without postoperative delirium and POCD. There was a significant difference in the sub-analyses at baseline vs. 18 h
for IL-5 in the subjects with postoperative delirium or POCD and baseline vs. 6 and 18 h for IL-8 (see Table 2) in both groups. Right Column: The mea-
sured concentrations for both cytokines, as well plotted separately, for patients with and without POCD/delirium
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significant overall time trend in the postoperative
changes from the preoperative measure, the significance
of the mean postoperative changes was tested. For each
cytokine, the linear mixed effects model was applied
only including the group effect (i.e., POCD/delirium or
no POCD/delirium). Given that the group effect was not
significant, we tested if the mean change between the
postoperative and the preoperative level is significantly
different from 0 considering all the postoperative time
points and the two groups together. The correlation
among observations of the same subject is accounted for
by the random intercept model.
In the plasma, there was a significant increase after
surgery in the mean level of RAGE (p = 0.0064) (see
Additional file 4) and also a marginally significant de-
crease in IL-12p70 (p = 0.0735) were found by testing
the fixed intercept term of the linear mixed model. In
the CSF, a significant increase in the mean level of
IL-10 (p = 0.0421) and IFN-γ (p = 0.0420) and also a
marginally significant increase in TNF-α (p = 0.0885)
were detected.Cytokine profile in the patient who developed postoperative
delirium
In the patient with postoperative delirium, several plasma
cytokines were elevated at baseline relatively to the other
patients: calprotectin (5-fold elevation), MIP-1α (2-fold),
MIP-1β (3-fold), and IL-6 (14-fold) (see Additional files 1
and 4); these cytokines remained elevated at the later time
points. Baseline and postoperative values for several cyto-
kines were relatively lower than in the other patients: IFN-
α2 (4-fold decrease), IFN-γ (>20-fold), IL-4 (10-fold), IL-5
(20-fold), IL-12(p70) (>20-fold), and amyloid β-40 (5-fold).
In CSF, baseline values for calprotectin were relatively
increased (1.5-fold), while others were decreased: IFN-α2
(8-fold) and RAGE (20-fold). Several CSF cytokines in-
creased more pronouncedly over preoperative values than
in patients without delirium: IL-6 (2-fold), IL-8 (2–4-fold),
and calprotectin (2–25-fold). The increase of CSF IL-6,
IL-8, and MCP-1 persisted longer in this patient. RAGE
was initially 15-fold decreased with a relatively more
pronounced increase than in other patients, while early
anti-inflammatory IL-10 values were relatively (20-fold)
smaller.
Table 2 Standardized estimates and p values of the group effects and the contrasts for plasma. This table provides the standardized
estimates and p values for the group effects (POCD/delirium (DLR) or no POCD/DLR) and the contrasts for plasma in the linear mixed
effects model. The time*group interaction is not significant for any of the markers. Assessment of change at each postoperative time
point was only for the plasma cytokines that have a (marginally) significant overall time trend. The contrasts “change from the
preoperative measure to 3 h,” “change from the preoperative measure to 6 h,” and “change from the preoperative measure to
18 h” signify whether there was a significant change in the concentration of a specific marker at 3, 6, and 18 h after surgery
compared to the preoperative measurement
Marker (plasma) Change from the pre-op to 3 h Change from the pre-op to 6 h Change from the pre-op to 18 h POCD/delirium*
Plasma amyloid β-42 −0.4978 −1.9768* 0.1621 –
Plasma IL-5
Group 1 0.3460 1.8097 2.4810** 2.0170*
Group 0 −2.1696* −1.2485 1.3206
Plasma IL-6 0.6607 5.0300*** 7.5368*** –
Plasma IL-8
Group 1 2.7407** 7.0220*** 7.6799*** 2.0873*
Group 0 −0.0862 3.5706*** 4.1325***
Plasma IL-10 1.3315 2.9038*** 5.1079*** –
Plasma MCP-1 1.8755* 4.3376*** 1.8720* –
Plasma IL-6/IL-10 0.7498 1.6455 3.5501***
Plasma MIP-1α 2.9280** 2.7353** 1.2621 –
The standardized estimates were calculated by dividing the estimated values by the corresponding standard errors to achieve the same scale. The asterisks indicate the
level of significance for the hypothesis that the group effect/contrast is different from zero. For plasma IL-5 and plasma IL-8, the comparisons between postoperative
measures to the preoperative measure are displayed separately for the two groups (group 1 = POCD/DLR, group 0 = no POCD/DLR), since the groups’ main
effect is marginally significant for these two markers. Of note, the time*group interaction is still not significant. All values are in pg ml−1. See Fig. 2 for
explanation of the group effect on the differences between the preoperative (pre-op) measure and each postoperative measure
*0.05 < p value < 0.1; **0.01 < p value < 0.05; ***p value < 0.01
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Baseline values for several plasma cytokines were rela-
tively lower in patients that later developed to POCD:
IL-4 (10-fold lower), IL-5 (8-fold), IL-6 (8-fold), IL-12(p-70)
(20-fold), IFN-α2 (8-fold), and IFN-γ (4-fold). While the
other cytokines approximated preoperative values for
the patients with POCD postoperatively, several plasmaTable 3 Standardized estimates and p values of the group effects a
estimates and p values for the group effects (POCD/delirium (DLR) o
effects model. The statistical significance of change at each postope
cytokines that have a (marginally) significant overall time trend in th
measure. For these markers, neither of the group effect nor the time
excluded from the models. The contrasts “change from the preoper
to 6 h,” and “change from the preoperative measure to 18 h” signify
of a specific cytokine at 3, 6, and 18 h after surgery compared to the
Marker (CSF) Change from the pre-op to 3 h Change from the p
CSF IL-5 −2.0244* 0.7591
CSF IL-6 1.2427 2.5724**
CSF IL-8 0.3551 3.4991***
CSF IL-12p70 −0.0414 1.8853*
CSF MCP-1 0.4484 5.3716***
CSF MIP-1α 3.0862** 3.3400***
CSF MIP-1β 3.9098*** 4.0916***
CSF IL-8/IL-10 0.2125 −1.8157*
*0.05 < p value < 0.1; **0.01 < p value < 0.05; ***p value < 0.01cytokine levels remained relatively lower in these patients:
IFN-α2 (3–20-fold), IL-12(p70) (>20-fold), and IL-4 (5–
20-fold). In CSF, some cytokines were relatively higher
at baseline: IFN-α2 (6-fold), amyloid β-40 (2-fold), and
IL-10 (3-fold). IL-10 values remained relatively elevated
throughout the observation period (3-fold) in patients
who developed POCD.nd the contrasts for CSF. This table provides the standardized
r no POCD/DLR) and the contrasts for CSF in the linear mixed
rative time point was tested as a contrast only for the CSF
e changes at postoperative time points from the preoperative
*group interaction was significant, and therefore, they were
ative measure to 3 h,” “change from the preoperative measure
whether there was a significant change in the concentration
preoperative measurement. All values are in pg ml−1
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and POCD prior to surgery
Preoperatively, plasma IL-6 was 14-fold higher at base-
line in the one patient who developed delirium; for
calprotectin, more than 5-fold higher values, and for
plasma, MIP-1β more than 3-fold higher values were
observed. Conversely, plasma IFN-α2 was 4-fold lower,
IL-4 was 10-fold lower, IL-5 was 20-fold lower, IFN-γ
and IL-12(p70) were more than 20-fold lower, Aβ-40
and Aβ-42 were more than 5-fold lower in this pa-
tient. In CSF, IFN-α2 and RAGE baseline levels were
more than 10-fold lower in the patient with postoper-
ative delirium.
Patients who developed POCD had 3-fold increased in
baseline levels of plasma IL-10, 2-fold increased in base-
line of CSF Aβ-40, and 6-fold increased in baseline levels
of CSF IFN-α. Baseline values for plasma IFN-α2, IL-4,
IL-5, and IL-6 were decreased 8-fold, and IL-12(p70)
more than 10-fold.
Potential plasma markers that reflect central nervous
system inflammatory changes
Cytokines with significant plasma-CSF correlations were
IL-6 (r = 0.47), IL-8 (r = 0.51), MIP-1α (r = 0.70), and
MIP-1β (r = 0.43). Correlations of other cytokines
between plasma and CSF values were not significant.
Discussion
We observed substantial elevations in proinflammatory
cytokines in both plasma and CSF after aseptic surgery
(Tables 2 and 3). The pronounced changes in CSF cyto-
kines compared to plasma for several cytokines (MCP,
MIP-1α, MIP-1β) provide evidence for substantial in-
flammatory activity in the central nervous system. In
particular, the statistically significant increases in plasma
IL-5, IL-6, IL-8, MCP-1, MIP-1α, and RAGE and of anti-
inflammatory IL-10 suggest a substantial activation of
key pathways of the immune response. The activation of
CSF IL-5, IL-6, IL-8, MCP-1, MIP-1α, and MIP-1β indi-
cates that chemoattraction of monocytes may play a key
role similar to what had been previously observed in
preclinical studies [14, 18, 41]. Moreover, the cytokine
pattern changes suggest an immunological response that
includes B-cell stimulation, immunoglobulin secretion,
activation of T-cells, eosinophil and neutrophil granulo-
cytes, and simultaneous activation of anti-inflammatory
pathways. Release of mitochondrial damage-associated
molecular patterns from femur fracture reamings also
activate neutrophils, which release IL-8 and MMP9 that
contribute to remote organ injury [42, 43].
Due to its sample size, this was a feasibility study with
predominantly descriptive findings. Our results cannot
determine any causal association of cytokine changes
with postoperative cognitive changes. However, therewere marginally significant differences in the postoper-
ative changes of plasma IL-5 and IL-8 from baseline in
patients with and without postoperative cognitive
changes (Fig. 2 and Table 2). This result provides a
starting point for future research.
In addition, our preliminary results show that proin-
flammatory plasma cytokines were substantially ele-
vated in the patient who developed delirium. Moreover,
a persistent increase in proinflammatory cytokines IL-6,
IL-8, and MCP-1 was observed in the CSF of this pa-
tient. It is noteworthy that this patient, while meeting
criteria for elective surgery, was among the older
patients in our cohort and among these with more co-
morbidities. It remains to be proven whether preopera-
tive subclinical inflammation may be a predictor for
postoperative delirium.
Patients who developed POCD had decreased levels of
several anti- and proinflammatory cytokines. Equally,
our findings for POCD are limited by the size of the
dataset and the relatively discrete signs of POCD that
were observed in 60 % of the patients. Further studies
are needed to confirm these alterations.
Based on our results, an important consideration for
future work may be the altered levels of several cyto-
kines at baseline in patients who later developed POCD
or delirium. Currently, the significance of these alter-
ations is unclear and needs to be investigated in future
studies with larger sample size. Research to further elu-
cidate these alterations may be useful to identify patients
who are at risk for postoperative surgical changes. How-
ever, while significant correlations between plasma and
CSF samples were present for IL-6, IL-8, MIP-1α, and
MIP-1β, correlations were negligible for other cytokines.
This is a potentially important result of our work, since
it may indicate limits to the utility of measurements
of some cytokines in more readily available plasma
samples, and the potentially usefulness of this ap-
proach for others. Our results support the conclusions
from a recent meta-analysis [44] that found a correl-
ation between POCD and the peripheral markers of
IL-6 and S100β [44] but indicate limited applicability
of plasma approaches for other cytokines.
The scientific context of our results contains animal
studies that demonstrate that surgical stimulus activates
the immune system even under aseptic conditions [10].
Several preclinical studies have established inflammation
of the central nervous system as a pathogenic mechanism
for cognitive dysfunction [12–15, 45]. Release of proin-
flammatory mediators including damage-associated
molecular patterns (DAMPs), such as HMGB1, into
the circulation have been shown to impair the blood-
brain barrier permeability after orthopedic surgery in
mice [14]. These cytokines converge into activation of
the innate immune system by convergence on NF-кB
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pattern recognition receptors (toll-like receptors 2 and
4 as well as receptor for advanced glycation end products)
on immunocytes. Through a permeable blood-brain
barrier, peripheral monocyte-derived macrophages ac-
cess the brain parenchyma. These are attracted by sig-
naling from the hippocampal MCP-1, a chemokine that
regulates migration and infiltration of C–C motif recep-
tor 2-expressing cells [41, 46, 47]. These processes have
been associated with memory dysfunction in preclinical
models of POCD, and strategies to block macrophage
infiltration and/or excessive proinflammatory mediators
have been successful in reducing these memory deficits
[14, 48]. Macrophage-specific IкB kinase (IKK)β coordi-
nates activation of NF-кB; when it is deleted, it pre-
vents the blood-brain barrier disruption and infiltration
of bone marrow-derived macrophages into the hippo-
campus following surgery [48]. Learning and memory
processes rely on the hippocampus. Rodent studies
have shown that increased expression of cytokines and
DAMPs in rodent’s hippocampus following surgery was
associated with cognitive decline [12, 16, 17]. Potential
mediators identified in animal models include IL-1β
[12], IL-6, TNF-α, and HMGB1 [16, 18]. Existing clin-
ical studies show accumulating evidence that the CSF’s
isolation from inflammatory reactions (immune privil-
ege) [49] may not be sustained perioperatively. Baune
et al. [50] reported a correlation between plasma IL-8
levels and cognitive performance in 369 community-
dwelling elderly subjects. Beloosesky and coworkers
[19] investigated the functional status and plasma cyto-
kine levels in 41 hip fracture patients. They reported
significantly higher plasma C-reactive protein and IL-6
kinetics curves in patients with preoperatively impaired
mental status. Recent studies in patients undergoing
emergency surgery reported that preoperative inflam-
matory markers were elevated in plasma and CSF [20]
[21] and that the extent of this inflammatory reaction
might correlate with the degree of postoperative cogni-
tive decline [20]. In these studies, the cause of the ob-
served biomarker increase cannot be clearly attributed
to surgery.
The change in CSF/plasma albumin ratio after aseptic
peripheral surgery [22] indicates an alteration in the
blood-brain barrier permeability in the perioperative
period. When evaluating plasma and CSF samples for
up to 30 h postoperatively, a consistent upregulation of
CSF IL-6, a transient increase in CSF IL-8, a delayed
increase in PGE2, and undetectable IL-1β, TNF-α, and
IL-10 in CSF [25] were found.
Several investigations have been performed in one pa-
tient population [22, 23, 25, 26]. Bromander et al. [23]
investigated changes in CSF and serum in 35 patients
undergoing knee arthroplasty surgery preoperatively, 3and 24 h postoperatively. It was determined that IL-2,
IL-8, IL-10, and IL-13 were increased to more than
500 % of their initial concentrations, while TNF content
doubled [23]. However, the concurrent administra-
tion of bupivacaine in these studies may have af-
fected the reported results. Bupivacaine has known
anti-inflammatory properties [29–31, 51] and has
been associated with chemical meningitis [27, 28]. Of
note, patients in our study group received a single
dose of bupivacaine at the time of placement of the
catheter with no subsequent administrations.
Tang [24] measured cytokines in 11 patients under-
going endoscopic surgery to correct idiopathic nasal
CSF drip under general anesthesia. Mean CSF Aβ-42
remained unchanged, but total-tau and phosphorylated-
tau181P increased progressively until 48 h after surgery.
CSF IL-10, S100β, IL-6, and TNF-α were increased at
24 h. Their results may indicate neuronal damage and/
or aggravation of existing conditions. However, the
underlying CSF rhinorrhea [24] implies a breach of the
blood-brain barrier, potentially causing direct immune
activation in the CSF, and meningitis is a potential
complication [52]. In addition, the condition is fre-
quently associated with intracranial hypertension [53],
and fluorescein was injected via the lumbar catheter
into the CSF during this surgery [54]. Cape and co-
workers [55] assessed 43 patients aged >60 years with
acute hip fracture for delirium before and 3–4 days
after surgery. CSF samples were taken at the induction
of spinal anesthesia. Delirium was diagnosed in eight
patients before surgery; 17 patients developed delirium
after surgery. The authors found that CSF IL-1β was
significantly higher in patients with new-onset delirium
compared to patients without delirium and that CSF to
serum IL-1β ratios were higher in delirious than non-
delirious patients. CSF IL-1ra was significantly higher
in patients with delirium before surgery compared to
new-onset delirium.
In the context of the above literature, our study is the
first to demonstrate significant perioperative changes in
a wide range of inflammatory markers in a setting with-
out trauma and with minimal injury to the cerebrospinal
space. Interestingly, these findings are more pronounced
in CSF than in plasma, which could indicate that they
originate from the central nervous system.
There are, however, several potential limitations to our
study. We used CAM to determine the presence of post-
operative delirium. CAM was developed as a screening
instrument for delirium but has high sensitivity and spe-
cificity. When compared with the delirium rating scale,
which has ten features, CAM measured 9/10 features
except for physical disorder [56]. Whether using the de-
lirium rating scale will yield different results will need to
be evaluated by future studies. In addition, the follow-up
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small sample size, our study results will need validation
by a larger study. We included a broader age range of
patients in order to optimize patient recruitment. The
inclusion of older subjects may result in a higher inci-
dence of postoperative delirium or POCD. Additional
considerations include more frequent CSF and plasma
sampling over a more extended period to consider other
than the effect of circadian variations [57]. Moreover,
it is currently unknown to what extent intravenous
sedation [58] and a single bolus injection of bupiva-
caine for spinal anesthesia affects cytokine levels in
CSF and plasma. An inflammatory response as a result
of the in-dwelling catheter cannot be excluded from
our data. Preoperative medications, pain, and use of
opioids and other drugs postoperatively may as well
affect cognitive status. Lastly, idiosyncrasies of the
surgical procedure [59, 60], such as tourniquet use
[60, 61, 62] reaming of the femur [42, 43] with poten-
tial for fat emboli, and cementing of the prosthesis
[63], may influence the results. Tourniquet times were
21.0 (20.7) min. Its role as a cofactor in this study is
probably small, since cytokine patterns in the two pa-
tients with the longest tourniquet time (about 60 min)
were not discernible from the remaining patients.
Similarly, there was no difference in cytokine patterns
in the patient that did not undergo reaming of the
femur and cementing (data not shown).
Conclusions
In summary, our results demonstrate increased inflam-
matory activity in plasma and CSF in the perioperative
period and shed more light on the complex inflamma-
tory mechanisms occurring during and after surgery.
These results corroborate previous studies [23, 25] that
a proinflammatory response based on IL-6 and IL-8 is
present in CSF and, less markedly, in plasma after aseptic
surgery. In addition, we found elevated levels of the
HMGB1 receptor RAGE, consistent with previously re-
ported elevated levels of HMGB1 [16, 18, 64] and TNF-α
[13, 23] in both animal and clinical studies. Moreover, our
results and previous work [23] establish a role for the
anti-inflammatory cytokine IL-10. The role for IL-1β
requires further clarification; while elevated levels were
found in animal studies [12], we and others [25] were
unable to reproduce this finding after aseptic surgery in
humans. Further studies need to elucidate the crosstalk
between systemic markers of inflammation and those
present in the CSF. While we found significant alterations
in some cytokines and substantial alterations in others in
plasma and CSF from patients with postoperative cogni-
tive changes, further research is needed to elucidate po-
tential contributions to the pathogenesis of postoperative
delirium and POCD.Additional files
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